An amazing humor piece from my friend Valerie Groth... the kind that makes you do a laugh-cry, because at first you laugh because it's funny, and then you cry because it's true: index.medium.com/why-sending-us…

Truth from my husband Daniel Tawfik

We need to remove the administrative burdens of treating patients and spend more time building relationships with them - listen to their stories, and learn their beliefs. It's not just about finding the right prescription, it's understanding how you can heal them as a whole.

Read more about the story of Dr. Meredith Halks Miller here by Elana Miller, MD: x.com/elanamd/status… #WIM #WIMmonth #WomenInSTEM

My mom, Dr. Meredith Halks Miller, is starting to get the recognition she deserves for her original research that led to the founding of GRAIL: economist.com/business/2021/… The Economist #WomenInSTEM Proud of you mom

The power of the pen. Elana Miller, MD wrote about her mother’s research that led to the founding of GRAIL. A Fast Company article has been amended to include Dr. Meredith Halks-Miller’s contribution to science, & recent articles in The Economist and WSJ lead with her discovery.

My husband Daniel Tawfik is launching his tech healthcare venture, Zen Patient, which makes it simple to launch a DTC telehealth platform. The traditional paradigm of healthcare delivery is changing, for the better. So proud of you baby and glad to be on your rocketship :-)

For decades, scientists have attributed the decline in fertility after age 35 mainly to chromosomal errors in aging eggs. Yet new evidence suggests the process begins earlier—and within the cellular machinery that maintains egg quality and longevity. A new study examined the use

GLP-1 medications are often framed as weight-loss drugs. But the biology tells a much bigger story. In Episode 1 of our GLP-1 & Longevity Series, the Healthspan clinical team explores why this class of medications may represent one of the most important medical developments of

In Episode 1 of our GLP-1 & Longevity Series, Dr. Jim Lanzilotti — architect of Healthspan’s GLP-1 Longevity Protocol — joins the clinical team to examine what GLP-1 receptor activation is actually doing inside the body. Rather than focusing on body weight alone, the discussion